France's Carmat Files for Insolvency as Shares Are Suspended
Medical device firm struggles with financial challenges.
French artificial heart manufacturer Carmat has filed for insolvency and had its shares suspended, signaling deep financial distress for the pioneering medtech company.
The firm cited severe liquidity issues and difficulties securing fresh investment despite the clinical promise of its life-saving technology.